Sanara MedTech (SMTI) Depreciation & Amortization (CF) (2016 - 2025)
Sanara MedTech's Depreciation & Amortization (CF) history spans 15 years, with the latest figure at $668396.0 for Q4 2025.
- For Q4 2025, Depreciation & Amortization (CF) fell 58.44% year-over-year to $668396.0; the TTM value through Dec 2025 reached $3.9 million, down 19.85%, while the annual FY2025 figure was $3.9 million, 19.85% down from the prior year.
- Depreciation & Amortization (CF) reached $668396.0 in Q4 2025 per SMTI's latest filing, down from $1.0 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.6 million in Q4 2024 to a low of $90591.0 in Q1 2021.
- Average Depreciation & Amortization (CF) over 5 years is $775612.9, with a median of $814598.5 recorded in 2022.
- Peak YoY movement for Depreciation & Amortization (CF): skyrocketed 434.81% in 2022, then tumbled 58.44% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $201007.0 in 2021, then skyrocketed by 305.12% to $814316.0 in 2022, then skyrocketed by 34.44% to $1.1 million in 2023, then skyrocketed by 46.92% to $1.6 million in 2024, then crashed by 58.44% to $668396.0 in 2025.
- Per Business Quant, the three most recent readings for SMTI's Depreciation & Amortization (CF) are $668396.0 (Q4 2025), $1.0 million (Q3 2025), and $1.1 million (Q2 2025).